000172039 001__ 172039
000172039 005__ 20210129214348.0
000172039 037__ $$aFZJ-2014-05588
000172039 041__ $$aEnglish
000172039 1001_ $$0P:(DE-Juel1)131816$$aCoenen, Heinrich Hubert$$b0$$eCorresponding Author$$ufzj
000172039 1112_ $$a3rd Conference on PET/MR and SPECT/MR$$cKos Island$$d2014-05-19 - 2014-05-21$$wGreece
000172039 245__ $$aRecent radochemical developments for authentically labelled bi-modal PET(SPECT)/MR-probes
000172039 260__ $$c2014
000172039 3367_ $$0PUB:(DE-HGF)6$$2PUB:(DE-HGF)$$aConference Presentation$$bconf$$mconf$$s1414997756_19697$$xOther
000172039 3367_ $$033$$2EndNote$$aConference Paper
000172039 3367_ $$2DataCite$$aOther
000172039 3367_ $$2ORCID$$aLECTURE_SPEECH
000172039 3367_ $$2DRIVER$$aconferenceObject
000172039 3367_ $$2BibTeX$$aINPROCEEDINGS
000172039 536__ $$0G:(DE-HGF)POF2-333$$a333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)$$cPOF2-333$$fPOF II$$x0
000172039 536__ $$0G:(DE-HGF)POF2-89573$$a89573 - Neuroimaging (POF2-89573)$$cPOF2-89573$$fPOF II T$$x1
000172039 7001_ $$0P:(DE-Juel1)144465$$aBuchholz, Martin$$b1$$ufzj
000172039 7001_ $$0P:(DE-Juel1)131849$$aSpahn, Ingo$$b2$$ufzj
000172039 7001_ $$0P:(DE-Juel1)157902$$aVanasschen, Christian$$b3$$ufzj
000172039 7001_ $$0P:(DE-Juel1)131818$$aErmert, Johannes$$b4$$ufzj
000172039 7001_ $$0P:(DE-HGF)0$$aNeumaier, B.$$b5
000172039 773__ $$y2014
000172039 909CO $$ooai:juser.fz-juelich.de:172039$$pVDB
000172039 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131816$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000172039 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)144465$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000172039 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131849$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000172039 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)157902$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000172039 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131818$$aForschungszentrum Jülich GmbH$$b4$$kFZJ
000172039 9132_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bPOF III$$lKey Technologies$$vDecoding the Human Brain$$x0
000172039 9131_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000172039 9131_ $$0G:(DE-HGF)POF2-89573$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vNeuroimaging$$x1
000172039 9141_ $$y2014
000172039 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000172039 980__ $$aconf
000172039 980__ $$aVDB
000172039 980__ $$aI:(DE-Juel1)INM-5-20090406
000172039 980__ $$aUNRESTRICTED